U.K. signs deal to buy 90 million doses of experimental coronavirus vaccine

British officials say they have signed a deal to buy 90 million doses of experimental coronavirus vaccines being developed by the pharmaceutical giant Pfizer and others.

The British government said in a statement Monday that it had secured access to a vaccine candidate being developed by a Pfizer and BioNTech, in addition to another experimental vaccine researched by Valneva.

Britain had previously signed a deal with AstraZeneca to provide 100 million doses of the coronavirus vaccine being tested by Oxford University, which is expected to announce further results later Monday.

Get breaking National news

For news impacting Canada and around the world, sign up for breaking news alerts delivered directly to you when they happen.

Sign up for breaking National newsletter Sign Up

By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy.

“Millions of people could be vaccinated against coronavirus,” the government statement said, citing the three different vaccines it has now invested in.

1:50 Russian hackers accused of targeting global COVID-19 vaccine research

Although it is still unclear which if any of the vaccines will ultimately prove effective against the virus, Britain and other rich countries are already investing in the vaccines to ensure there is enough manufacturing capacity to deliver any successful candidate.

Vaccines typically take years to develop and more than a dozen are in the early stages of testing globally.